Life with hereditary angioedema

Then and now

Charles Joseph Lane, J. Andrew Grant, Dane Dougherty

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Originally identified in 1882, hereditary angioedema (HAE) is a debilitating and potentially fatal disorder. Although a number of therapies have been identified, many are relatively ineffective or are associated with significant side effect concerns that limit their efficacy. Fortunately, the 2008 approval of plasma-derived C1 esterase inhibitor concentrate for disease prophylaxis provides clinicians with a novel and effective treatment unencumbered with severe side effect concerns for those with this debilitating disorder. However, despite advances in modern medicine, HAE remains a condition marked by a myriad of symptoms that mimic a range of other disorders, from allergic angioedema to acute abdomen, and accurate diagnosis remains a concern. Using articles from the medical literature from the late nineteenth and early twentieth centuries documenting families with HAE, we will review its history and pathophysiology as well as describe current trends in its diagnosis and treatment. Additionally, we will emphasize the humanistic impact of the disorder by describing the real-life experiences of a contemporary family who has documented their experience with HAE across 7 generations.

Original languageEnglish (US)
Pages (from-to)144-151
Number of pages8
JournalPostgraduate Medicine
Volume124
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Hereditary Angioedemas
Complement C1 Inhibitor Protein
Angioedema
Modern 1601-history
Acute Abdomen
Therapeutics
History

Keywords

  • Angioedema
  • Bradykinin
  • C1 esterase inhibitor
  • Complement
  • Hereditary angioedema
  • Pedigree

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lane, C. J., Andrew Grant, J., & Dougherty, D. (2012). Life with hereditary angioedema: Then and now. Postgraduate Medicine, 124(1), 144-151. https://doi.org/10.3810/pgm.2012.01.2527

Life with hereditary angioedema : Then and now. / Lane, Charles Joseph; Andrew Grant, J.; Dougherty, Dane.

In: Postgraduate Medicine, Vol. 124, No. 1, 01.2012, p. 144-151.

Research output: Contribution to journalArticle

Lane, CJ, Andrew Grant, J & Dougherty, D 2012, 'Life with hereditary angioedema: Then and now', Postgraduate Medicine, vol. 124, no. 1, pp. 144-151. https://doi.org/10.3810/pgm.2012.01.2527
Lane, Charles Joseph ; Andrew Grant, J. ; Dougherty, Dane. / Life with hereditary angioedema : Then and now. In: Postgraduate Medicine. 2012 ; Vol. 124, No. 1. pp. 144-151.
@article{e4473a4128ca46f8a9179efd3c6dafb6,
title = "Life with hereditary angioedema: Then and now",
abstract = "Originally identified in 1882, hereditary angioedema (HAE) is a debilitating and potentially fatal disorder. Although a number of therapies have been identified, many are relatively ineffective or are associated with significant side effect concerns that limit their efficacy. Fortunately, the 2008 approval of plasma-derived C1 esterase inhibitor concentrate for disease prophylaxis provides clinicians with a novel and effective treatment unencumbered with severe side effect concerns for those with this debilitating disorder. However, despite advances in modern medicine, HAE remains a condition marked by a myriad of symptoms that mimic a range of other disorders, from allergic angioedema to acute abdomen, and accurate diagnosis remains a concern. Using articles from the medical literature from the late nineteenth and early twentieth centuries documenting families with HAE, we will review its history and pathophysiology as well as describe current trends in its diagnosis and treatment. Additionally, we will emphasize the humanistic impact of the disorder by describing the real-life experiences of a contemporary family who has documented their experience with HAE across 7 generations.",
keywords = "Angioedema, Bradykinin, C1 esterase inhibitor, Complement, Hereditary angioedema, Pedigree",
author = "Lane, {Charles Joseph} and {Andrew Grant}, J. and Dane Dougherty",
year = "2012",
month = "1",
doi = "10.3810/pgm.2012.01.2527",
language = "English (US)",
volume = "124",
pages = "144--151",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "1",

}

TY - JOUR

T1 - Life with hereditary angioedema

T2 - Then and now

AU - Lane, Charles Joseph

AU - Andrew Grant, J.

AU - Dougherty, Dane

PY - 2012/1

Y1 - 2012/1

N2 - Originally identified in 1882, hereditary angioedema (HAE) is a debilitating and potentially fatal disorder. Although a number of therapies have been identified, many are relatively ineffective or are associated with significant side effect concerns that limit their efficacy. Fortunately, the 2008 approval of plasma-derived C1 esterase inhibitor concentrate for disease prophylaxis provides clinicians with a novel and effective treatment unencumbered with severe side effect concerns for those with this debilitating disorder. However, despite advances in modern medicine, HAE remains a condition marked by a myriad of symptoms that mimic a range of other disorders, from allergic angioedema to acute abdomen, and accurate diagnosis remains a concern. Using articles from the medical literature from the late nineteenth and early twentieth centuries documenting families with HAE, we will review its history and pathophysiology as well as describe current trends in its diagnosis and treatment. Additionally, we will emphasize the humanistic impact of the disorder by describing the real-life experiences of a contemporary family who has documented their experience with HAE across 7 generations.

AB - Originally identified in 1882, hereditary angioedema (HAE) is a debilitating and potentially fatal disorder. Although a number of therapies have been identified, many are relatively ineffective or are associated with significant side effect concerns that limit their efficacy. Fortunately, the 2008 approval of plasma-derived C1 esterase inhibitor concentrate for disease prophylaxis provides clinicians with a novel and effective treatment unencumbered with severe side effect concerns for those with this debilitating disorder. However, despite advances in modern medicine, HAE remains a condition marked by a myriad of symptoms that mimic a range of other disorders, from allergic angioedema to acute abdomen, and accurate diagnosis remains a concern. Using articles from the medical literature from the late nineteenth and early twentieth centuries documenting families with HAE, we will review its history and pathophysiology as well as describe current trends in its diagnosis and treatment. Additionally, we will emphasize the humanistic impact of the disorder by describing the real-life experiences of a contemporary family who has documented their experience with HAE across 7 generations.

KW - Angioedema

KW - Bradykinin

KW - C1 esterase inhibitor

KW - Complement

KW - Hereditary angioedema

KW - Pedigree

UR - http://www.scopus.com/inward/record.url?scp=84856874978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856874978&partnerID=8YFLogxK

U2 - 10.3810/pgm.2012.01.2527

DO - 10.3810/pgm.2012.01.2527

M3 - Article

VL - 124

SP - 144

EP - 151

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 1

ER -